The European Medicines Agency's (EMA) management board has signed off on the regulator's clinical trials transparency policy, adopting several changes along the way the regulator said would make the ...
In a landmark decision with wide-ranging implications for drugmakers around the globe, the European Medicines Agency (EMA) has announced it will soon require pharmaceutical companies whose products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results